Ada Health, a consumer-facing digital health company, is partnering with Big Pharma company Pfizer to launch an online test-to-treatment platform for patients with COVID-19, The platform will connect patients with healthcare providers for evaluation of their symptoms and treatment options. It will help determine if a patient has a high risk of developing severe COVID-19. The platform will be available in 36 states and Washington D.C.
It’s ‘Telehealth vs. No Care’: Doctors say Congress risks leaving patients vulnerable
Digital Diagnostics, an AI company for diabetic retinopathy, is partnering with Tamer Healthcare, an integrated healthcare and wellness firm in Saudi Arabia, to distribute its IDx-DR product there. The deal also allows for future AI-based therapies to expand and develop in the country in conjunction with the Saudi Localization Plan. Last August, Digital Diagnostics signed an agreement with Kingdom of Saudi Arabia's Ministry of Investment to develop the company’s AI technology within the country.
Five Questions: 7wireVentures’ Alyssa Jaffee
Teal Health, an at-home cervical cancer screening company, raised $8.8 million in a seed funding round. The test is designed to increase a woman’s confidence and adherence to screen for primary HPV and Pap cytology triage. The company said funding will enable it to expedite product development, clinical testing and approval from the Food and Drug Administration.
FTC alleges GoodRx shared consumer’s health info with Facebook, Google
Alto Neuroscience, a virtual psychiatry company, secured $25 million in new equity funding along with a $35 million credit facility in a Series B funding round. The funding will support four Phase 2 trial readouts and advance fits Precision Psychiatry Platform which uses a series of data points from behavioral tasks and wearables to match patients with the company’s drugs.
More deals and funding rounds:
AnswersNow, a virtual autism therapy startup, closed $11 million in Series A funding.
Accenture, a global professional consulting company, acquired Bionest, a strategy and consulting firm for digital health and life science organizations.
Science 37, a clinical trial tech company, acquired a life science platform from Vault Health, which offers COVID-19 testing and health-screening services for employers.
Sherlock Biosciences, an AI-enabled diagnostics solutions company, acquired Sense Biodetection, a rapid molecular test platform.
NOCED, a telehealth company that offers obsessive compulsive disorder treatment, announced a $34 million funding round to expand its OCD-specialty therapist network and enhance the company’s analytics and payer relationships.
Clearsense, a healthcare analytics company, raised $50 million in a Series D funding round.
UptimeHealth, a predictive analytics platform, closed a $4.5 million Series A round.
C-mo Medical Solutions, a wearable cough-monitoring device, raised around $5.2 million in a seed extension round.
TBD Health, a hybrid women’s and sexual healthcare provider, announced a $4.4 million seed round.
Levels, a diet and activity company, raised $7 million in a Series A extension round.
Aluna, a respiratory care company, completed a 15.3 million Series B funding round.
Healistic, a mobile app connecting insurance, providers and patients in the UK, raised around $1.2 million in a pre-seed round.
DrFirst, a care collaboration and medication management company, acquired Diagnotes, a clinical communication messaging app.
Tivity Health, a virtual mental wellness platform, acquired Burnalong, a digital health and fitness platform.
If there is a digital health funding or M&A deal that we missed from this past week here, please email us.
Digital Health Business & Technology’s data team contributed to this roundup.
